Multiple thrombophilic factors in a patient with Budd-Chiari syndrome

Clinical and Laboratory Haematology

Volumn 24, Issue 1, 2002, Pages 61-63

  Iannaccone, L ^a   Brancaccio, V ^a   Amitrano, L ^a   Guardascione, M A ^a   Margaglione, M ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Budd Chiari; Factor V Leiden; Prothrombin mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PROTEIN C; PROTHROMBIN; WARFARIN; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; GENE IDENTIFICATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; LIVER ANGIOGRAPHY; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN THROMBOSIS; BLOOD; GENETICS; HETEROZYGOTE; LIVER VEIN THROMBOSIS; MALE; MUTATION; THROMBOCYTHEMIA; THROMBOPHILIA;

ADULT; CASE REPORT; FACTOR V; HEPATIC VEIN THROMBOSIS; HETEROZYGOTE; HUMAN; MALE; MUTATION; PROTHROMBIN; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOPHILIA; VENOUS THROMBOSIS; HUMANS;

EID: 0036008664     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.00196.x     Document Type: Article

References (22)

1. Factor V Leiden and other coagulation factor mutation affecting thrombotic risk
2. Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene
3. Antithrombin III deficiency: An etiology of Budd-Chiari syndrome
4. Hepatic vein thrombosis in a patient with mutant 20210A allele
5. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis
6. Factor V Leiden related Budd-Chiari syndrome
7. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
8. Budd-Chiari syndrome associated with factor V Leiden mutation: A report of 6 patients
9. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study
10. Modified test for activated protein C resistance
11. Coexistence of factor V Leiden and factor II A20210G mutations and recurrent venous thromboembolism
12. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation
13. Budd-Chiari syndrome: Combination of genetic defects and the use of oral contraceptives leading to hypercoagulability
14. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
15. Budd-Chiari syndrome in a patient heterozygous for both factor V Leiden and the G20210A mutation on the prothrombin gene
16. Anti-phospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome
17. Interrelated risk factors for venous thromboembolism
18. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
19. Venous thrombosis: A multicausal disease
20. Budd-Chiari syndrome attributed to protein C deficiency
21. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
22. Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting